Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioGenex Laboratories

BioGenex Laboratories?uq=oeHSfu7P
1981 FOUNDED
PUBLIC STATUS
201-300 EMPLOYEES
BGNX STOCK SYMBOL
Description

Provider of automated systems that streamline operations in anatomic pathology and tools for the detection and diagnosis of cancer and infectious diseases. The company offers monoclonal and polyclonal antibodies for immunohistochemistry (IHC) staining on formalin-fixed, paraffin-embedded tissue, as well as for detecting a range of antigens.

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
PINX
Primary Office
  • 4600 Norris Canyon Road
  • San Ramon, CA 94583
  • United States

+1 (925) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BioGenex Laboratories’s full profile, request a free trial.

BioGenex Laboratories Financials Summary

In Thousands,
USD
TTM
31-Dec-2010
FY 2010
31-Dec-2010
FY 2009
31-Dec-2009
FY 2008
31-Dec-2008
Revenue 14,364 14,364 16,850 15,553
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BioGenex Laboratories Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore BioGenex Laboratories‘s full profile, request access.

Request full access to PitchBook

BioGenex Laboratories Executive Team (3)

Name Title Board
Seat
Contact
Info
Krishan Kalra Ph.D Founder, Chairman & Chief Executive Officer
David Sheldon Chief Financial Officer
George Su Ph.D Director, Operations

BioGenex Laboratories Board Members (1)

Name Representing Role Since Contact
Info
0000000 00000 00.0 BioGenex Laboratories Founder, Chairman & Chief Executive Officer 000 0000